|
CompazineDrug - Compazine The trade name of the product as shown on the labeling.
Dosage -
CAPSULE, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Prochlorperazine Maleate
Strength -
EQ 10MG BASE
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
021019
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Oct 6, 1999
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Glaxosmithkline
Compazine
Prochlorperazine Edisylate Eq 5mg Base/ml Injectable; Injection
Compazine Eq 5mg Base/5ml Syrup; Oral Prochlorperazine Edisylate Eq 5mg Base/5ml Syrup; Oral Prochlorperazine Edisylate Eq 5mg Base/5ml Syrup; Oral Compazine Eq 10mg Base Capsule, Extended Release; Oral Compazine Eq 10mg Base Capsule, Extended Release; Oral Prochlorperazine Edisylate Eq 5mg Base/ml Injectable; Injection Prochlorperazine Edisylate Eq 5mg Base/ml Injectable; Injection Prochlorperazine Edisylate Eq 5mg Base/ml Injectable; Injection Prochlorperazine Edisylate Eq 5mg Base/ml Injectable; Injection NewDrugInformation |